Significantly higher CAIX expression was found in triple negative breast cancer subtypes when compared to luminal ER+ breast cancers (Supplementary Figure S3), in accordance with other studies [11, 12, 28]. This evidence concerns the gene CA9 and triple-negative breast carcinoma.